The lack of correlation of the tested genes and obesity in ALL survivors together with changes in leptin/soluble leptin receptor plasma levels suggest, that influence of the selected genetic polymorphisms was not very potent. The gene discussed is LEPR; the disease is acute lymphoblastic leukemia.